Abstract: An energy ray irradiation device includes: an irradiator that faces a conveyance surface and irradiates an ink on a recording medium conveyed on the conveyance surface with an energy ray; an enclosure part that encloses a space between the irradiator and the conveyance surface by a plate member including a first plate member that extends from an end of the irradiator on an upstream side in a conveyance direction toward the conveyance surface on an upstream side of the end; and a first blowout part that supplies a non-reactive gas that does not react with the ink from an end of the first plate member on the upstream side in the conveyance direction into the enclosure part.

Abstract: The present invention provides a highly functional polyethylene fiber exhibiting reduction of change in their physical properties in a wide range of temperatures for processing for products and in a wide range of temperatures for usage as products, thereby enabling improvement of dimensional stability. In addition, the present invention provides a highly functional polyethylene fiber exhibiting a high degree of dye exhaustion to be obtained in a simple dyeing operation, and excellent color fastness. The highly functional polyethylene fiber of the present invention is characterized in that an intrinsic viscosity [?] is higher than or equal to 0.8 dL/g, and not higher than 4.9 dL/g, ethylene is substantially contained as a repeating unit thereof, and a maximum thermal shrinkage stress is less than or equal to 0.4 cN/dtex in TMA (thermo-mechanical analysis), and a thermal shrinking percentage at 100° C. is less than or equal to 2.5%.

Abstract: A portable manipulation command input device, including a sub-console panel attachable to and removable from an automatic lathe apparatus main unit, and includes an input unit to receive input of a manipulation command to the automatic lathe apparatus main unit, a display unit to display information on the automatic lathe apparatus main unit, and a radio communication unit to communicate with the automatic lathe apparatus main unit. The sub-console panel includes a detection unit and a control unit formed with the automatic lathe apparatus main unit. The detection unit includes a radio ID tag and a radio ID reader detecting the sub-console panel being placed within a predetermined range of the automatic lathe apparatus main unit. Depending on a detection result by the detection unit, the control unit allows or restricts manipulations of the automatic lathe apparatus main unit, and allows display of the information even when restricting the manipulations.

Abstract: A polyethylene fiber characterized by having an intrinsic viscosity [?] of 0.8 dL/g or more and less than 5 dL/g; being composed of a repeating unit substantially derived from ethylene; having pores formed inside of the fiber; having an average diameter of the pores of ranging from 3 nm to 1 ?m when the diameter is measured, by each pore being approximated by a column, at a contact angle of 140 degrees, in a mercury intrusion method; a porosity of the pores of ranging from 1.5% to 20%; and having a tensile strength greater than or equal to 8 cN/dtex.

Abstract: A portable manipulation command input device, including a sub-console panel attachable to and removable from an automatic lathe apparatus main unit, and includes an input unit to receive input of a manipulation command to the automatic lathe apparatus main unit, a display unit to display information on the automatic lathe apparatus main unit, and a radio communication unit to communicate with the automatic lathe apparatus main unit. The sub-console panel includes a detection unit and a control unit formed with the automatic lathe apparatus main unit. The detection unit includes a radio ID tag and a radio ID reader detecting the sub-console panel being placed within a predetermined range of the automatic lathe apparatus main unit. Depending on a detection result by the detection unit, the control unit allows or restricts manipulations of the automatic lathe apparatus main unit, and allows display of the information even when restricting the manipulations.

Abstract: The Present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.

Abstract: The present invention provides a highly functional polyethylene fiber excellent in the cut resistance, has a high dimensional stability at about room temperature at which products are used, has a high shrinkage rate and stress, and excellent in forming processability when processed at a low temperature much less than a melting point of a polyethylene. And the present invention provides a highly functional polyethylene fiber excellent in processability at a low temperature, wherein an intrinsic viscosity [?] is higher than or equal to 0.8 dL/g, and is not higher than 4.9 dL/g, ethylene is substantially contained as a repeating unit, and a thermal stress at 40° C. is lower than or equal to 0.05 cN/dtex, and a thermal stress at 70° C. is higher than or equal to 0.05 cN/dtex, and is not higher than 0.25 cN/dtex. Further the present invention provides strings, ropes, woven/knitted textiles, and gloves thereof.

Abstract: The present invention provides a highly functional polyethylene fiber exhibiting reduction of change in their physical properties in a wide range of temperatures for processing for products and in a wide range of temperatures for usage as products, thereby enabling improvement of dimensional stability. In addition, the present invention provides a highly functional polyethylene fiber exhibiting a high degree of dye exhaustion to be obtained in a simple dyeing operation, and excellent color fastness. The highly functional polyethylene fiber of the present invention is characterized in that an intrinsic viscosity [?] is higher than or equal to 0.8 dL/g, and not higher than 4.9 dL/g, ethylene is substantially contained as a repeating unit thereof, and a maximum thermal shrinkage stress is less than or equal to 0.4 cN/dtex in TMA (thermo-mechanical analysis), and a thermal shrinking percentage at 100° C. is less than or equal to 2.5%.

Abstract: The Present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.

Abstract: The present invention provides a highly functional polyethylene fiber excellent in the cut resistance, has a high dimensional stability at about room temperature at which products are used, has a high shrinkage rate and stress, and excellent in forming processability when processed at a low temperature much less than a melting point of a polyethylene. And the present invention provides a highly functional polyethylene fiber excellent in processability at a low temperature, wherein an intrinsic viscosity [?] is higher than or equal to 0.8 dL/g, and is not higher than 4.9 dL/g, ethylene is substantially contained as a repeating unit, and a thermal stress at 40° C. is lower than or equal to 0.05 cN/dtex, and a thermal stress at 70° C. is higher than or equal to 0.05 cN/dtex, and is not higher than 0.25 cN/dtex. Further the present invention provides strings, ropes, woven/knitted textiles, and gloves thereof.

Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.

Abstract: The present invention provides a polyethylene fiber which can attain a high dye exhaustion rate, which indicates deep color, and which is excellent in dyeability and color fastness; a woven or knit textile that uses the polyethylene fiber, and that is excellent in cut-resistance and heat-retaining property, and a glove thereof. A polyethylene fiber of the present invention is characterized by having an intrinsic viscosity [?] of 0.8 dL/g or more and less than 5 dL/g; being composed of a repeating unit substantially derived from ethylene; having pores being formed from a surface of the fiber to an inside of the fiber; having an average diameter of the pores of ranging from 3 nm to 1 ?m when the diameter is measured, by each pore being approximated by a column, at a contact angle of 140 degrees, in a mercury intrusion method; a porosity of the pores of ranging from 1.5% to 20% 1; or a thermal conductivity in a fiber axis direction at a temperature of 300 K of ranging from 6 W/mK to 50 W/mK.

Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.

Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.

Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.

Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.

Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomeruloscierosis.

Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.

Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.

Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.